Christian Hinderer
15Patents
2h-index
8Co-inventors
43Inventor score
Filing activity: Sep 27, 2013 → Dec 29, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9770011B2 | Veterinary composition and methods for non-surgical neutering and castration | Chemistry; Metallurgy | 3 | Active |
| US11135313B2 | Intrathecal administration of adeno-associated-viral vectors for gene therapy | Emerging Cross-Sectional Technologies | 2 | Active |
| US11253612B2 | Gene therapy for treating mucopolysaccharidosis type II | Chemistry; Metallurgy | 1 | Active |
| US10780182B2 | Methods and compositions for treating metastatic breast cancer and other cancers in the brain | Chemistry; Metallurgy | 1 | Active |
| US11578341B2 | Compositions useful in treatment of spinal muscular atrophy | Chemistry; Metallurgy | 1 | Active |
| US10973929B2 | Gene therapy for treating mucopolysaccharidosis type I | Chemistry; Metallurgy | 0 | Active |
| US11890329B2 | AAV9-mediated gene therapy for treating mucopolysaccharidosis type I | Chemistry; Metallurgy | 0 | Active |
| US11591614B2 | Gene therapy for ceroid lipofuscinoses | Chemistry; Metallurgy | 0 | Active |
| US12221615B2 | GLP-1 and use thereof in compositions for treating metabolic diseases | Chemistry; Metallurgy | 0 | Active |
| US12428653B2 | Gene therapy for ceroid lipofuscinoses | Chemistry; Metallurgy | 0 | Active |
| US11819539B2 | Gene therapy for treating Mucopolysaccharidosis type II | Chemistry; Metallurgy | 0 | Active |
| US12416017B2 | Recombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration | Chemistry; Metallurgy | 0 | Active |
| US11117942B2 | AAV-EPO for treating companion animals | Chemistry; Metallurgy | 0 | Active |
| US11723989B2 | Gene therapy for mucopolysaccharidosis IIIB | Chemistry; Metallurgy | 0 | Active |
| US11865187B2 | Methods and compositions for treating metastatic breast cancer and other cancers in the brain | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.